Bardin Hill Management Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bardin Hill Management Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,300,182	Closed	-$2.84M	–	49
2019 Q4	$2.84M	Hold	3,300,182	–	–	0.47%	28
2019 Q3	$1.85M	Buy	3,300,182 +139,068	+4%	+$74.8K	0.32%	28
2019 Q2	$1.64M	Buy	3,161,114 +2,239,386	+243%	+$1.12M	0.23%	29
2019 Q1	$415K	Buy	+921,728	New	+$430K	0.07%	24
2016 Q4	–	Sell	-3,679,902	Closed	-$994K	–	39
2016 Q3	$994K	Buy	3,679,902 +1,440,000	+64%	+$365K	0.27%	18
2016 Q2	$538K	Buy	+2,239,902	New	+$385K	0.13%	25

Bardin Hill Management Partners's GCVRZ Position: Q1 2020 in Review

Bardin Hill Management Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 3,300,182 shares — an estimated $2.84M sold.

Bardin Hill Management Partners first reported a position in GCVRZ in Q2 2016 and held it in 6 quarters. The position peaked at $2.84M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Bardin Hill Management Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Bardin Hill Management Partners sold 3,300,182 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $2.84M.
Bardin Hill Management Partners first reported a position in Sanofi Contingent Value Rights in Q2 2016 and held it in 6 quarters.
Bardin Hill Management Partners's Sanofi Contingent Value Rights position peaked at $2.84M in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Bardin Hill Management Partners's 13F filing for Q1 2020, filed 15 May 2020.